The North America Mechanical Ventilator Market is expected to witness market growth of 11.2% CAGR during the forecast period (2021-2027).
COPD and asthma are the most prevalent respiratory conditions across the world. According to the WHO, COPD is the third leading cause of death globally, causing 3.23 million deaths in 2019. In November 2020, Philips introduced Ventilator BiPAP A40 Expiratory Flow Limitation (EFL), a noninvasive ventilator for COPD patients. With this, clinicians can detect EFL in hypercapnic COPD patients at the point of care, ensuring the delivery of optimal homecare therapy. Increased demand for home healthcare is anticipated to have a favorable impact on the demand for home care ventilators in the coming years.
Many manufacturers were flooded with orders during the pandemic. In March 2020, Philips announced that it ramped up the production of critical care products and solutions to support the diagnosis and treatment of patients with COVID-19. The company also increased the production of patient vital signs monitors and portable ventilators and consumables for invasive and noninvasive ventilation to treat a wide range of breathing conditions.
Advancements, such as spontaneous Breathing Trial (SBT), are used to assess the patient's ability to breathe while receiving minimal or no ventilator support and Auto TRAK, which improves patient experience.
As per the Society of Critical Care Medicine, the stock of hospital ventilators in the United States was around 160,000 units in the first quarter of 2020. Moreover, over 6.09 million active COVID-19 cases as of August 2020, and an estimated 960,000 Americans needed mechanical helped to breathe during the pandemic as per the American Association for Respiratory Care. Mechanical ventilators thus experienced a sudden spike in the demand in 2020 in the United States which is expected to boost the market growth.
According to a report by the Centers for Disease Control and Prevention (CDC), in March 2020, there were around 53% ICU admissions out of total hospitalizations due to COVID-19 infection. In addition, according to a research study by Silvio A. Ñamendys-Silva et al., published in Critical Care February 2021, in Mexico, about 15.3% of hospitalized patients required invasive mechanical ventilation (IMV), and 70.8% of patients received invasive mechanical ventilation (IMV) outside the ICU.
The US market dominated the North America Mechanical Ventilator Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $2,833.4 million by 2027. The Canada market is anticipated to grow at a CAGR of 13.7% during (2021 - 2027). Additionally, The Mexico market is expected to exhibit a CAGR of 12.7% during (2021 - 2027).
Based on Product Type, the market is segmented into Intensive Care Unit/Critical Care, Transport/Portable/Ambulatory, and Neonatal Care. Based on Age Group, the market is segmented into Adult, Geriatric, and Pediatric & Neonatal. Based on Component, the market is segmented into Devices and Services. Based on Mode, the market is segmented into Invasive Ventilation and Non-invasive Ventilation. Based on End User, the market is segmented into Hospital & Clinic, Ambulatory Surgical Center, Home Care, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Dragerwerk AG & Co. KGaA, Getinge AB, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Carl Reiner GmbH, Mindray Medical International Limited, and Vyaire Medical, Inc.
By Product Type
By Age Group
By Component
By Mode
By End User
By Country: US, Canada, Mexico, and Rest of North America.
COPD and asthma are the most prevalent respiratory conditions across the world. According to the WHO, COPD is the third leading cause of death globally, causing 3.23 million deaths in 2019. In November 2020, Philips introduced Ventilator BiPAP A40 Expiratory Flow Limitation (EFL), a noninvasive ventilator for COPD patients. With this, clinicians can detect EFL in hypercapnic COPD patients at the point of care, ensuring the delivery of optimal homecare therapy. Increased demand for home healthcare is anticipated to have a favorable impact on the demand for home care ventilators in the coming years.
Many manufacturers were flooded with orders during the pandemic. In March 2020, Philips announced that it ramped up the production of critical care products and solutions to support the diagnosis and treatment of patients with COVID-19. The company also increased the production of patient vital signs monitors and portable ventilators and consumables for invasive and noninvasive ventilation to treat a wide range of breathing conditions.
Advancements, such as spontaneous Breathing Trial (SBT), are used to assess the patient's ability to breathe while receiving minimal or no ventilator support and Auto TRAK, which improves patient experience.
As per the Society of Critical Care Medicine, the stock of hospital ventilators in the United States was around 160,000 units in the first quarter of 2020. Moreover, over 6.09 million active COVID-19 cases as of August 2020, and an estimated 960,000 Americans needed mechanical helped to breathe during the pandemic as per the American Association for Respiratory Care. Mechanical ventilators thus experienced a sudden spike in the demand in 2020 in the United States which is expected to boost the market growth.
According to a report by the Centers for Disease Control and Prevention (CDC), in March 2020, there were around 53% ICU admissions out of total hospitalizations due to COVID-19 infection. In addition, according to a research study by Silvio A. Ñamendys-Silva et al., published in Critical Care February 2021, in Mexico, about 15.3% of hospitalized patients required invasive mechanical ventilation (IMV), and 70.8% of patients received invasive mechanical ventilation (IMV) outside the ICU.
The US market dominated the North America Mechanical Ventilator Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $2,833.4 million by 2027. The Canada market is anticipated to grow at a CAGR of 13.7% during (2021 - 2027). Additionally, The Mexico market is expected to exhibit a CAGR of 12.7% during (2021 - 2027).
Based on Product Type, the market is segmented into Intensive Care Unit/Critical Care, Transport/Portable/Ambulatory, and Neonatal Care. Based on Age Group, the market is segmented into Adult, Geriatric, and Pediatric & Neonatal. Based on Component, the market is segmented into Devices and Services. Based on Mode, the market is segmented into Invasive Ventilation and Non-invasive Ventilation. Based on End User, the market is segmented into Hospital & Clinic, Ambulatory Surgical Center, Home Care, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Dragerwerk AG & Co. KGaA, Getinge AB, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Carl Reiner GmbH, Mindray Medical International Limited, and Vyaire Medical, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Intensive Care Unit/Critical Care
- Transport/Portable/Ambulatory
- Neonatal Care
By Age Group
- Adult
- Geriatric
- Pediatric & Neonatal
By Component
- Devices
- Services
By Mode
- Invasive Ventilation
- Non-invasive Ventilation
By End User
- Hospital & Clinic
- Ambulatory Surgical Center
- Home Care
- Others
By Country: US, Canada, Mexico, and Rest of North America.
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Dragerwerk AG & Co. KGaA
- Getinge AB
- Asahi Kasei Corporation (Zoll Medical Corporation)
- Hamilton Medical AG (Hamilton Bonaduz AG)
- Carl Reiner GmbH
- Mindray Medical International Limited
- Vyaire Medical, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Mechanical Ventilator Market by Product Type
Chapter 5. North America Mechanical Ventilator Market by Age Group
Chapter 6. North America Mechanical Ventilator Market by Component
Chapter 7. North America Mechanical Ventilator Market by Mode
Chapter 8. North America Mechanical Ventilator Market by End User
Chapter 9. North America Mechanical Ventilator Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Dragerwerk AG & Co. KGaA
- Getinge AB
- Asahi Kasei Corporation (Zoll Medical Corporation)
- Hamilton Medical AG (Hamilton Bonaduz AG)
- Carl Reiner GmbH
- Mindray Medical International Limited
- Vyaire Medical, Inc.
Methodology
LOADING...